Early Detection Research Network

LPAR3

Aliases:
This biomarker is also known as:
  • RP4-678I3,
  • FLJ98231,
  • LPA-3,
  • HOFNH30,
  • LPAR3,
  • endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 7,
  • Edg-7,
  • LPA3,
  • LP-A3,
  • LPA receptor 3,
  • EDG7,
  • lysophosphatidic acid receptor 3,
  • GPCR,

Description…

LPAR3, a multi-pass cell membrane protein, is a receptor for lysophosphatidic acid (LPA), a mediator of diverse cellular activities. LPAR3 seems to be coupled to the G(i)/G(o) and G(q) families of heteromeric G proteins. LPAR3 may play a role in the development of ovarian cancer. This protein is most abundantly expressed in prostate, testes, pancreas, and heart, with moderate levels in lung and ovary. There is no detectable expression in brain, placenta, liver, skeletal muscle, kidney, spleen, thymus, small intestine, colon, or peripheral blood leukocytes.

Datasets

There are no datasets associated with this biomarker.

Attributes
QA State: Under Review
Type: Protein
HGNC Name: LPAR3

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.